Medical News / ASH Meeting 2020: High COVID-19 False-Negative Rate Among Patients With Hematological Malignancies

There is a high false-negative rate of coronavirus disease 2019 (COVID-19) in patients with hematological malignancies, according to study findings presented at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition. The findings suggested the need to establish the diagnosis of COVID-19 quickly, as faster initiation of treatment was associated with better outcomes. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

The modes of multiple myeloma assessment and screening has progressed over decades in near-alignment with the ... read more
A new study presented at the American Society of Hematology (ASH) 2020 Annual Meeting this weekend ... read more
A mobile health (mHealth) app may help children manage pain and symptoms related to sickle cell ... read more
Cognitive and emotional functions in pediatric patients should not be overlooked when assessing potential for sickle ... read more